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Abstract
Background
Sri Lanka’s Anti Filariasis Campaign distributed 5 rounds of mass drug administration
(MDA with DEC plus albendazole) to all endemic regions in the country from 2002–2006.
Post-MDA surveillance results have generally been encouraging. However, recent studies have documented low level persistence of Wuchereria bancrofti in Galle district
based on comprehensive surveys that include molecular xenomonitoring (MX, detection
of filarial DNA in mosquitoes) results. The purposes of this study were to demonstrate the
use of MX in large evaluation units (EUs) and to field test different mosquito sampling
schemes.

Methodology/Principal Findings
Galle district (population 1.1 million) was divided into two EUs. These included a coastal
EU with known persistent LF and an inland EU with little persistent LF. Mosquitoes were
systematically sampled from ~300 trap locations in 30 randomly selected clusters (health
administrative units) per EU. Approximately 28,000 Culex quinquefasciatus were collected with gravid traps and tested for filarial DNA by qPCR. 92/625 pools (14.7%) from
the coastal EU and 8/583 pools (1.4%) from the inland EU were positive for filarial DNA.
Maximum likelihood estimates (MLE) for filarial DNA rates were essentially the same
when the same number of mosquito pools were collected and tested from 75, 150, or
300 trap sites (range 0.61–0.78% for the coastal EU and 0.04–0.07% for the inland EU).
The ability to use a smaller number of trap sites reduces the cost and time required for
mosquito sampling.
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Conclusions/Significance
These results suggest there is widespread persistence of W. bancrofti infection in the
coastal Galle EU 8 years after the last round of MDA in 2006, and this is consistent with
other data from the district. This study has shown that MX can be used by national programs
to assess and map the persistence of W. bancrofti at the level of large EUs in areas with
Culex transmission.

Author Summary
Lymphatic filariasis (LF) is a disabling neglected tropical disease that affects millions of
people in 73 countries. The Global Program to Eliminate Lymphatic Filariasis (GPELF) is
using mass drug administration (MDA) to reduce infections in humans below levels
required for sustained transmission by mosquitoes. Prior studies have shown that molecular xenomonitoring (MX, detection of filarial DNA in insect vectors) is useful for detecting
low-level persistence of W. bancrofti infection following MDA, but technical challenges
have prevented national programs from adopting this approach on a large scale. This
paper reports the first use of MX for post-MDA surveillance in large evaluation units.
CDC gravid traps were effective for collecting large numbers of Culex quinquefasciatus
mosquitoes, and filarial DNA was detected by qPCR. We found that MX is more sensitive
than other surveillance methods for detecting persistent W. bancrofti in communities and
that there is widespread, low-level persistence of infection in coastal Galle district (Sri
Lanka) 8 years after the last round of MDA. The systematic mosquito sampling protocol
used in this study should be feasible for use by national filariasis elimination programs to
assess and map the persistence of W. bancrofti in regions where the infection is transmitted by Culex mosquitoes.

Introduction
Lymphatic filariasis (LF) is a disfiguring and disabling disease that affects approximately 120
million people in 73 countries. The World Health Organization (WHO) initiated a Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000 that is largely based on repeated
annual cycles of mass drug administration (MDA) with albendazole together with either ivermectin (in Africa) or diethylcarbamazine (outside of Africa) to reduce infection rates and interrupt transmission. GPELF aims to eliminate LF as a public health problem in all countries by
the year 2020. With a target population of 1.4 billion, this is easily the largest disease intervention program initiated to date based on MDA; more than 6 billion medication doses were distributed to some 600 million people between 2000 and 2014 [1].
MDA has dramatically reduced LF infection rates and prevented new cases in many countries [2,3]. However, more work is needed to develop and test methods for determining
whether W. bancrofti has been eliminated from countries and regions following MDA. The
WHO now recommends use of transmission assessment surveys (TAS) to demonstrate interruption of transmission. TAS surveys use systematic sampling protocol to test 1st and 2nd grade
primary school children for filarial antigenemia, and they are powered to provide 95% certainty
that infection rates in children are less than 2%. While this is a useful surveillance tool, a recent
study showed that antibody testing of sentinel populations and molecular xenomonitoring
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(MX, detection of filarial DNA in vector mosquitoes by PCR) were more sensitive than TAS
for detecting persistent W. bancrofti in Sri Lanka [4]. MX relies on the ability of mosquitoes to
efficiently take up filarial parasites from human blood, and parasite DNA is detected in mosquito pools by PCR. Although MX has been used extensively in recent years to demonstrate
the impact of MDA on W. bancrofti in communities [4–8], no national LF elimination program has adopted MX as a routine method for post-MDA surveillance.
Sri Lanka was one of the first countries to implement a LF elimination program based on
WHO guidelines. The Sri Lankan Ministry of Health’s Anti Filariasis Campaign (AFC) distributed 5 annual rounds of MDA with albendazole plus diethylcarbamazine to all endemic regions
of the country between 2002 and 2006 [9]. Various types of surveillance have been conducted
since the MDA program ended in 2006. Post-MDA surveillance results (based on detection of
parasites in human blood by microscopy) have consistently shown microfilaremia rates lower
than the target value of 1% in all sentinel and spot check sites. However, recent studies have
provided evidence of persistent LF infection and transmission in several districts, and this is
especially worrisome in the Southern district of Galle.
Galle District, with a population of approximately 1.06 million, is located about 125 km
south of the country’s capital in Colombo. The district area is about 1,652 km2 (636 square
miles) with 73 km of coastline. Ecological conditions (annual rainfall 200–250 cm, mean temperature 25–28 C, and relative humidity levels often >80%) are favorable for mosquitoes. Survey data before and after the MDA program have consistently shown higher LF rates in coastal
areas that have low-lying low plains, low hills, extensive surface water, and higher human population densities than in inland areas of the district that have steep hills and better drainage.
It is well documented that Culex quinquefasciatus is the major W. bancrofti transmission
vector in Sri Lanka [10–13], and the traditional filariasis belt extends along the coast from Puttalam in the West around to Matara in the South. Some of these areas have poorly drained polluted water, latrine catch pits, coconut husk pits, and rice fields that are primary breeding areas
for Culex and other types of mosquitoes [14]. A devastating Tsunami in 2004 in this coastal
belt affected the topography in some areas in ways that may have increased mosquito densities
and disease transmission. However, there are no mapping data available on distribution of
breeding sites for C. quinquefasciatus in Sri Lanka or in Galle district.
The central Ministry of Health and Nutrition (MOH) divides districts into progressively
smaller health administrative units. Galle is divided into large Ministry of Health areas
(MOOH) with populations in the range of 22,000–95,000. Each MOOH area is comprised of
Public Health Inspector (PHI) areas, and these sub-district health administration units are
comprised of smaller Public Health Midwife (PHM) areas.
Galle had high rates of LF prior to the national LF elimination program, and government
surveys have shown that sentinel sites in this district have consistently had higher microfilaria
(Mf) rates than most sites in other districts in the years since the MDA program ended.
Although the AFC used the district as an implementation unit for MDA, Galle was divided
into two evaluation units (a high-risk coastal EU and low-risk inland EU) for monitoring and
evaluation.
The AFC conducted transmission assessment surveys (TAS) in these EUs in 2012–2013
according to WHO guidelines, and both EUs easily passed the WHO threshold. However,
recent surveys in two public health inspector (PHI) areas in Galle district showed high rates of
filarial DNA in Culex quinquefasciatus and high rates of anti-filarial antibodies in primary
school children [4]. These results suggested that there are hotspots with persistent W. bancrofti
transmission in Galle.
The current study was conducted to test a scheme for systematic sampling of mosquitoes so
that MX could complement TAS for assessing residual filariasis activity by national filariasis
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elimination programs. The study also aimed to map areas with persistent W. bancrofti in Galle
district and to compare MX results with results from an extensive population survey for microfilaremia that was conducted by the AFC in 2013. While MX has been previously used to assess
the impact of MDA on persistent W. bancrofti in populations, this study reports the first time
that it has been used by a national LF elimination program to detect persistent W. bancrofti at
the scale of large EUs.

Materials and Methods
Ethics statement
We obtained consent from household members to place CDC gravid traps on their property.
The Microfilaria surveys were conducted as a public health activity by the Anti Filariasis Campaign, Sri Lanka Ministry of Health. Written consent was obtained from all adults. Participation of children required written consent from at least one parent or guardian plus assent by
the child. Unique identifiers of human participants were not used in this study.

Study location
Galle district is divided into 19 Medical Officers of Health (MOOH) divisions, and each of
these are comprised of smaller health administrative units called Public Health Midwife
(PHM) areas that were used as evaluation areas (EAs) for the cluster surveys described in this
paper. There are 340 PHM areas in Galle district with a mean population of approximately
3,000 (range 669–8025). The district was divided into two evaluation units (EU) for post-MDA
surveillance. These included a high risk coastal EU with 210 PHMs in 11 MOOH areas and a
low risk inland EU with 126 PHMs in 8 MOOH areas. Three of the 11 high risk MOOH areas
are not located near the coast, but in this study they were considered to be part of the high risk
coastal EU based on historical LF data, detection of Mf positive cases in routine surveys, and
because of they are bordering areas with high Mf rates. In the 2013 census, approximately
24,600 households were listed in the coastal EU and 17,400 households were in the inland EU.

Mosquito sample size and sampling method
The mosquito surveys used cluster sampling based on systematic selection of households (HH)
to assess prevalence of Wuchereria bancrofti DNA in C. quinquefasciatus species [15]. The
study was designed to collect and test 300 pools of 25 mosquitoes per pool collected from 300,
150, and 75 HH locations. PHM maps, census data and voter registries were used to identify
the HH locations in each of these areas. Thirty PHMs were randomly selected as evaluation
areas (EAs) in each of the two EUs studied using Survey Sample Builder (SSB) software (http://
www.ntdsupport.org/resources/transmission-assessment-survey-sample-builder). The sampling interval was calculated by dividing the estimated number of HH in each EU by the number of HH that were needed for mosquito trap placement in the EU (300). The starting HH for
each PHM was selected at random from the census list, and other HH for trap placement in
that PHM were selected using the sampling interval. Subsets of 150 and 75 trapping sites were
randomly chosen from the pool of 300 per EU for collection of 2 and 4 mosquito pools per
trap. To allow for anticipated 10% HH refusal rate for permitting mosquito trap placement,
trap locations were increased to 320, 156, 76 or 81, respectively.

Mosquito collection and DNA preparation
The mosquito surveys were performed between December 2013 and September 2014. The long
duration was due to administrative issues and not because of time requirements for the work.
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Mosquitoes were collected with CDC gravid traps (Model 1712, John W. Hock Company,
Gainesville, FL) with liquid bait that attracts Cx. quinquefasciatus [4,16]. The traps were placed
outdoors in shaded areas adjacent to houses after obtaining consent from the residents. Traps
were set to collect mosquitoes from dusk to dawn for 1 to 3 nights. A second trap was placed
next to selected houses in some locations in order to collect the required number of mosquitoes. This was commonly done when four pools were required from a trapping location. Traps
that did not yield enough mosquitoes to form pools were moved to a new location. Mosquitoes
were collected from an average of ten (range 6–19) locations in each of the 60 PHM areas.
Culex quinquefasciatus were manually sorted to select only gravid, semigravid or blood fed
females and pooled in groups of up to 25. Pools were placed in 2 ml seal-rite tubes and dried as
previously described [4]. Tubes with mosquitoes were labeled with barcode stickers and these
numbers were scanned into cellphones and associated with GPS coordinates. The dried mosquitoes were transferred to the AFC central laboratory in Colombo for DNA isolation and
qPCR testing.

DNA isolation from mosquito pools
Genomic DNA extraction of pools of mosquitoes (1–25) was performed as previously
described [17]. The extracted DNA samples in 200 μl of Diethylpyrocarbonate (DEPC) treated
water was stored at -20 C in 1.5 ml sterile polypropylene tubes with barcode stickers.

PCR testing of mosquito pools for detecting W. bancrofti DNA
W. bancrofti DNA was detected in mosquito DNA samples that were tested in duplicate by
quantitative PCR (qPCR) in microtiter plates with an Applied Biosystems 7300 Real Time PCR
System (Life technologies, California, USA) as previously described [18,19]. Positive and negative control samples were included in each qPCR assay. Mosquito DNA samples with borderline Ct values (38) and those with inconsistent results in duplicate wells were retested.
Samples with Ct values >38 were considered to be negative. All DNA extractions and qPCR
assays were performed in AFC laboratories in Colombo.

Community surveys for microfilaremia
The AFC conducted a large scale night blood smear survey between March and August, 2013.
Households were selected for the survey using the WHO guidelines [20] based on the probability proportional to estimated size (PPES) of the population with the goal of testing approximately 3% of the population (38,000 people drawn from all PHMs in the district). A maximum
of 4 people per household were sampled between the ages of 2 and 70 years. Two to four teams
collected blood in night blood surveys that started no earlier than 20:30 hr. Each team included
a public health inspector, a blood collector, a helper, and a supervisor. It took six months to
complete the night blood surveys, but additional time was required for processing of blood
smears and microscopy.

Blood tests for W. bancrofti microfilariae
Microfilaria (Mf) testing was performed with a measured volume of 60 μl of night blood. Finger
prick blood samples were collected with One Touch Ultra Soft lancet holders with sterile, single
use lancets (LifeScan, Inc., Milpitas, CA). Two-spot blood smears of 30 μl each were stained
with Giemsa, and Mf were detected by microscopy.
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Data collection and data management
PHM numbers, household locations, trap numbers, pool numbers, and pool PCR test results
were entered into Motorola (Motorola Solutions, Inc., Schaumburg, IL) Blur phones using preloaded survey forms with a LINKS data collection platform (http://www.linkssystem.org/).
Specimens and laboratory qPCR test results were linked to trap locations using barcode stickers
(Partnered Print Solutions, Dacula, GA). Data were downloaded as Microsoft Excel files
(Microsoft Corporation, Redmond, WA) for analysis at AFC and at Washington University.
Demographic information and Mf smear results were entered onto paper forms for the Mf surveys, and this information was later transferred into Excel spreadsheets (Microsoft Corporation, Redmond, WA).

Spatial analysis
GPS coordinates for mosquito sampling sites were obtained with cellphones. Coordinates were
plotted using ArcGIS 10.2.1 (ESRI, Redlands, CA).

Statistical methods
qPCR results were expressed as the percentages of positive pools and trap sites by PHM and
EU. Filarial DNA rates in mosquitoes (maximum likelihood estimates with 95% confidence
intervals) were calculated with PoolScreen 2.0.3 software as previously described [21,22]. Separate PoolScreen estimates (maximum likelihood estimates or MLE with 95% confidence intervals) were calculated for approximately 300 pools from 300 trap sites, 300 pools from 150 trap
sites, and 300 pools from 75 trap sites from 30 PHMs (evaluation areas) in each of the two EUs.
In order to assess filarial DNA rates in mosquitoes collected in Galle district as a single EU,
the merged results from 2 EUs were analyzed by calculating mosquito DNA rates in 30 PHMs
randomly selected from the 60 PHMs in two EUs that were sampled in the study. This process
was repeated 30 times to assess variability in estimates obtained with different PHM samples.
Results were analyzed by ANOVA and the significance of differences was assessed by the
Tukey method. Data analysis was performed with Statistical Analysis Software (SAS, version
9.2, SAS Institute Inc. Cary, North Carolina). Some figures were produced with Graphpad
Prism 6 (GraphPad Software, Inc., La Jolla, CA).

Consent procedures
We obtained consent from household members to place CDC gravid traps on their property.
The Mf surveys were conducted as a public health activity by the Anti Filariasis Campaign, Sri
Lanka Ministry of Health. Written consent was obtained from all adults. Participation of children required written consent from at least one parent or guardian plus assent by the child.
Unique identifiers of human participants were not used in this study. However, AFC followed
up to treat Mf carriers identified during night blood surveys with anti-filarial medications
according to WHO guidelines.

Results
Mosquito collections and filarial DNA rates in mosquitoes
Approximately 28,700 blood fed, gravid or semigravid C. quinquefasciatus mosquitoes were
collected from more than 600 trap locations in 60 PHMs (30 in each EU) between December
2013 and September 2014 (Table 1). Mosquitoes were sorted into 1208 pools with 1–25 mosquitoes per pool (see Tables 1 and 2). Each pool contained mosquitoes from a single trap location. While 89.5% of pools contained 25 mosquitoes (1081/1208), some pools were smaller,
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Table 1. Filarial DNA rates in Culex quinquefasciatus in 2 evaluation units (EU) in Galle district, Sri Lanka.
Galle EUs

No. of MOOH
areas

Human
population

No. of PHMs
surveyed

No. of pools
tested

No. of mosquitoes
tested

No. of Positive
pools(%)

Filarial DNA rates
%, (95% CI)

Coastal/ high
risk

11

609,932

30

625

15,245

92(14.7)

0.63 (0.5–0.8)

Inland/ low
risk

8

457,006

30

583

13,472

8 (1.4)

0.06 (0.02–0.11)

Total

19

1,066,938

60

1208

28,717

100(8.3)

0.36 (0.29–0.45)

doi:10.1371/journal.pntd.0004722.t001

because few mosquitoes were trapped in some collection sites despite placement of traps for up
to 3 nights. Indeed, zero mosquitoes were collected in 45 trap locations. Factors such as higher
altitude, very effective water drainage, and paradoxically, excessive rain affected collections at
these locations.
qPCR results by EU are summarized in Table 1. Combined results from both EUs showed
that 100 of 1208 pools (8%) were positive for filarial DNA. 16/30 PHM areas in the coastal EU
and 3/30 (10%) in the inland EU had at least one positive pool (range 1–16). Filarial DNA rates
in mosquitoes exceeded provisional targets for filarial DNA [4,19] of 0.25% for maximum likelihood and 1% for the upper confidence limit of the estimate in 12 of 30 PHMs in the coastal
EU and in 4 of 30 PHMs in the inland EU (Fig 1). Thus W. bancrofti DNA rates were high in
most areas within the coastal EU and much lower in the inland EU. Some of the inland PHMs
with positive qPCR results were adjacent to areas in the coastal EU with high filarial DNA rates
in mosquitoes.
Figs 2 and 3 provide information on the general location of mosquitoes with filarial DNA in
the PHM areas sampled in this study. Filarial DNA was detected in mosquitoes in 22% (70/
Table 2. Estimated filarial DNA rates in Culex quinquefasciatus pools in 2 evaluation units (EU) in Galle, Sri Lanka.
EU

Coastal

Inland

PHMs

Trap
Locations

Samples

No. of
pools

No. of
mosquitoes

No. (%) of positive
pools

Filarial DNA rates (%) in
mosquitoes (95% CI)

No. (%) of
positive
mosquito
trap
locations

30

317

1- Pool

317

7801

44 (13.9)

0.61 (0.42–0.83)

44/317
(14)

30

150

2- Poola

300

7428

47 (15.7)

0.67 (0.47–0.91)

40/150
(27)

30

150

2- Poola

300

7341

52 (17.3)

0.78 (0.56–1.04)

43/150
(28)

30

74

4- Pool

292

7163

43 (14.8)

0.65 (0.45–0.90)

26/74
(35)

30

317

1- Pool

317

7449

3 (0.95)

0.04 (0.01–0.12)

3/317
(1)

30

150

2- Poola

300

7119

4 (1.3)

0.06 (0.01–0.14)

4/150
(3)

30

150

2- Poola

300

6845

5 (1.2)

0.07 (0.02–0.17)

5/150
(3)

30

77

4- Pool

266

6211

3 (1.1)

0.05 (0.01–0.18)

3/77 (4)

Filarial DNA rates were detected by qPCR. Rates of ﬁlarial DNA in mosquitoes (maximum likelihood and 95% CI) were estimated using PoolScreen 2.03.
Filarial DNA rates in mosquitoes were very similar whether 300 pools were sampled at 300, 150, or 75 collection sites.
Two sets of 150 areas with 300 pools each were randomly chosen for calculations.

a

doi:10.1371/journal.pntd.0004722.t002
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Fig 1. Filarial DNA rates (MLE with 95% confidence intervals) for mosquitoes collected in the coastal
(panel A) and inland (panel B) EUs in Galle district. Lines with the same color show results from PHMs
within a single MOOH area. Filarial DNA rates exceeded the target rate of 0.25% in 16 of 60 PHMs, and the
upper confidence limit exceeded the target of 1% in all these 16 PHMs. The solid line in the panel A and B
show the provisional target for MX. The dotted lines in the two panels are at the recommended upper
confidence limits for filarial DNA rates in mosquitoes.
doi:10.1371/journal.pntd.0004722.g001

317) of trap locations in the coastal EU and in 3% (8/317) of trap locations in the inland EU.
Although the number of mosquitoes collected from each trap location varied because of the
sampling scheme, Fig 3 shows that mosquitoes with filarial DNA were widely distributed in
coastal areas.

Comparison of different sampling schemes for estimating rates of filarial
DNA in mosquitoes
Table 2 shows that similar results were obtained when similar numbers of mosquitoes were
tested in 300 pools that were collected from approximately 75, 150, or 300 sampling locations
with 4, 2 or 1 pool per site, respectively. Mosquito DNA rates were also similar when different
numbers of collection sites were used in the inland EU, although it was not possible to obtain
enough mosquitoes for 4 pools from some collection sites.
Table 3 shows results that would have been obtained if Galle district had been considered as
a single EU rather than as two EUs. The results shown are the mean and SD of 30 separate randomly selected samples of 30 EAs drawn from the entire district. The results show that the
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Fig 2. Percentages of mosquito trap locations in coastal PHM areas that yielded mosquito pools that
were positive for filarial DNA by qPCR. Bars with the same color show results from PHMs within a single
MOOH area. Twenty-two % of trap locations captured mosquitoes with filarial DNA, but some locations had
much higher rates.
doi:10.1371/journal.pntd.0004722.g002

estimates were essentially the same whether mosquitoes were sampled from 316, 153, or 70
trap locations. More importantly, the results show that the parasite DNA rate in the combined
EU was lower and intermediate between the rates observed in the coastal and inland EUs.

Fig 3. Distribution of mosquito trapping locations tested for filarial DNA in 60 PHM areas in Galle
district. Molecular xenomonitoring results show trap locations with no mosquito pools positive for filarial DNA
(coastal: green and inland: blue waypoints), and traps with one or more positive pools for filarial DNA are
shown in red (in the coastal and inland EU areas).
doi:10.1371/journal.pntd.0004722.g003
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004722
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Table 3. Analysis of molecular xenomonitoring results using pools of Culex quinquefasciatus in Galle Public Health Midwife (PHM) areas.
No. of trap sites per EU

Pools per trap site

Mean No. of pools

No. of ﬁlarial DNA positive pools

MLE mean % (±SD)

P valuea

316

1

316

24

0.34% (0.10)

0.9651

153

2

306

25

0.37% (0.09)

0.9867

70

4

280

23

0.35% (0.13)

0.9416

Analysis of 30 randomly selected PHMs from a total of 60 PHMs from 2 EU (mean values of 30 repetitions).
PHM areas are evaluation areas (EA)
MLE, maximum likelihood estimates using PoolScreen 2.03.
a

P values are based on Chi-square for the comparison of results with different trapping protocols.

High P values indicate no signiﬁcant difference between the means of each iteration.
doi:10.1371/journal.pntd.0004722.t003

Although the filarial DNA rate in mosquitoes from the district wide EU exceeded the provisional target of 0.25%, the diluting effect of results from the inland areas is clear (the MLE for
the coastal EU and for the entire district were 0.67% vs. 0.35%, respectively). This emphasizes
the importance of creating EU’s so that transmission risks within them are as uniform as practicable [23].

Microfilaria survey results
Night blood testing was performed with 38,065 samples collected from all PHMs and all
MOOH areas in Galle district. Only 52 slides were positive for an overall rate of 0.14%
(Table 4). 12 out of 19 MOOH areas recorded at least 1 Mf-positive subject (range 1–22), and
the mean (SD) Mf count in positive slides was (17 ± 30; range 1–177). As expected, Mf rates
were much higher in MOOH areas in the coastal EU than in the inland EU, and 47 of 52
(90.4%) Mf positives identified in the district-wide survey lived in coastal areas. The Balapitiya
MOOH area in the coastal EU had the highest number of Mf-positive subjects and the highest
Mf rate (0.9%); 22 of 52 (42%) Mf positive subjects were from this MOOH area. However, Mf
rates were much higher (range 1%-4.64%) in 12 of the 340 PHMs surveyed. These were
Talpe (1.39%), Panagamuwa (1.72%), Paragahathota (4.64%), Galmangoda (3.45%), Balapitiya
(4.42%), Randombe (1.73%), Wellabada (1.12%), Dalawella (1.01%), Maliduwua (1.41%),
Kumbhalwella-2 (2.75%), Aluthwatta (1.26%), and Mawita (1.13%), respectively. Ten of the
PHMs with Mf rates >1% were in the coastal EU and two were in the inland EU.

Comparison of filarial DNA rates in mosquitoes and microflaremia rates
in humans
Table 4 shows Mf survey results and MX results by MOOH area. Note that all PHM areas were
sampled in the Mf survey while MX was performed in only a few PHM areas per MOOH area.
Despite this difference, the MX and Mf data both indicated widespread persistence of LF in the
coastal EU with much lower rates in the inland EU. The two MOOH areas with the highest Mf
rates (Balapitiya and Galle) also had the highest MX signals (% mosquito pools positive for
filarial DNA). However, not all areas had consistent results, and three MOOH areas (Ambalangoda, Hikkaduwa, and Habaraduwa) with very high MX positivity had low Mf rates. This may
have been due to small samples in the Mf surveys or to differences in the areas sampled, as
mentioned above.
Two PHM areas (in Imaduwa and Yakkalamulla MOOHs in the inland EU) also had mosquitoes that were positive for filarial DNA (7% and 2% pools positive, Fig 1) and the same
MOOH areas had Mf carriers detected by night blood surveys (Mf rate 0.75%) (Table 4). On
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Table 4. Human infection rates and parasite DNA rates from 19 MOOH areas in Galle, Sri Lanka.
Community microﬁlaria (Mf) rates
Evaluation Unit
(EU)

MOOH area

No. of PHM
tested

No. people
tested

Coastal

Akmeemana

20

2341

Ambalangoda

18

1940

Balapitiya

22

Bope-poddala
Elpitiya
Galle MC

Inland

No. of PHM
tested

No. of pools
tested

No. of pools positive
(%, 95% CI)

4 (0.2, 0.07–0.4)

3

93

1 (0.1, 0.01–0.3)

3

69

7 (10, 5.0–19.5)

2445

22 (0.9, 0.6–1.4)a

3

68

26 (38, 27.6–50.1)a

16

2271

1 (0.04, 0.01–0.2)

2

44

2 (4.5, 1.3–15.1)

23

2145

0 (0)

4

71

0 (0)

15

3146

13 (0.4, 0.2–0.7)a

2

60

16 (26.7, 17.1–39)a

18 (19, 12.6–28.5)

Gonapinuwala

8

793

1 (0.1, 0.02–0.7)

1

17

0 (0)

Habaraduwa

19

2339

2 (0.1, 0.02–0.3)

3

39

11 (28, 16.5–43.7)

Hikkaduwa

34

3795

3 (0.1, 0.03–0.2)

4

71

8 (11, 5.8–20.6)

Induruwa/
Bentota

16

1801

0 (0)

3

45

4 (9, 3.5–20.7)

Karandeniya

18

2072

0 (0)

2

48

0 (0)

Total

209

25088

47 (0.2, 0.1–0.2)

30

625

92 (14.7, 12.2–17.7)

Baddegama

25

2719

0 (0)

6

138

0 (0)

Imaduwa

17

1867

1 (0.1, 0.01–0.3)

4

79

6 (7, 3.5–15.6)

Neluwa

13

1021

2 (0.2, 0.05–0.7)

3

40

0 (0)

Niyagama

13

1362

0 (0)

3

62

0 (0)

Thawalama

13

1026

0 (0)

3

50

0 (0)

Udugama/
Nagoda

23

2061

1 (0.1, 0.01–0.3)

5

85

0 (0)

WeliwitiyaDivithura

10

955

0 (0)

2

48

0 (0)

17

1966

1 (0.1, 0.01–0.3)

4

81

2 (2, 0.7–8.5)

131

12977

5 (0, 0.02–0.09)

30

583

8 (1.4, 0.7–2.7)

Yakkalamulla
Total
a

No. of Mf positive
(%, 95% CI)

Mosquito ﬁlarial DNA rates

Areas with high W. bancrofti prevalence in humans with microﬁlariae and ﬁlarial DNA rates in mosquitoes.

doi:10.1371/journal.pntd.0004722.t004

the other hand, no positive mosquito pools were detected in other PHMs that were located in
MOOH areas in the inland EU where Mf carriers were identified (Table 4). Again, this may be
because not all PHMs were sampled for MX, and because persistent filarial infections following
MDA can be highly focal.
Table 5 summarizes Mf and MX results for 15 PHM areas in 6 coastal MOOH areas that
were tested by both survey methods. These results illustrate the dramatic heterogeneity of persistent W. bancrofti in Galle district. They also show that MX surveys based on relatively small
numbers of mosquito pools are more sensitive for detecting persistent W. bancrofti infections
than Mf testing with sample sizes in the range of 91–267 per PHM area. Only 5 of 15 PHMs
had positive signals by Mf testing while 10 of 15 PHMs had positive mosquito pools by qPCR.
On the other hand, one PHM with no positive mosquito pool (out of 17 tested) had a positive
Mf signal with 1 positive smear out of 101 tested.

Spatial distribution of filarial DNA in fed or gravid Culex quinquefasciatus
Fig 3 shows the location of gravid traps that yielded mosquitoes that were tested for filarial
DNA by qPCR. Mosquitoes with filarial DNA were widely distributed in coastal areas and also
present in a few inland areas. S1 Fig shows a more detailed map for MX results from three
PHM areas that were tested in the Balapitiya MOOH area. Filarial DNA was detected in
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Table 5. Microfilaremia in humans and filarial DNA rates in mosquitoes by Public Health Midwife area in the coastal evaluation unit.
MOOH area
Ambalangoda

PHM

No. people
tested

No. (%, CI) of Mf
positive

No. of mosquito pools
tested

Number of Mosquitoes
tested

No. (%) of pools
positive

Patabendumulla

96

0

17

425

6 (35)

Batapola Central

103

0

31

775

1 (1)

Diddeliya

101

0

21

525

0

Wathugedra

113

0

24

600

9 (37)

BrahmanawattaN

109

1 (1)

20

487

12 (60)

Galvehera

130

0

24

600

5 (21)

Megalle

267

0

32

783

6 (19)

Kumbhalwella

255

7 (3,1.3–5.6)

28

700

10 (36)

Gonapinuwala

Gonapinuwala

102

1 (1,0.2–5.3)

17

421

0

Bopepoddala

Kapuhempala

151

0

24

586

0

Ukwattha-East

109

0

20

500

2 (10)

Gammedegoda

112

0

21

525

5 (24)

Katudampe

119

0

11

275

0

Wawulagoda

101

1 (1,0.2–5.4)

17

425

3 (18)

Weragoda

91

0

22

550

0

Balapitiya

Galle

Hikkaduwa

doi:10.1371/journal.pntd.0004722.t005

mosquitoes collected in 58% of trapping sites in Balapitiya. These results show that MX is useful for identifying areas with persistent filariasis, and this information could be useful for targeting additional measures to interrupt transmission.

Discussion
Prior studies have shown persistence of W. bancrofti in populations following MDA in several
areas in Sri Lanka including Galle district, despite the fact that all EUs in the country easily
passed TAS performed according to WHO guidelines. This study is the first to demonstrate the
value of MX for detecting persistent filarial infection at the level of EUs with large populations.
The study was designed to compare MX results for two EUs within one district that were previously shown to have very different rates of persistent infection based on Mf testing and TAS
results.
The MX results confirmed that there was much more W. bancrofti infection in the coastal
EU than in the inland EU, and they also showed that transmission was widespread in the
coastal EU (population 610,000) and not confined to one or two small hotspots. The results
also showed that MX was more sensitive than night blood surveys for detecting persistent W.
bancrofti activity in this study area. We found that MX is feasible for national LF elimination
programs. Areas identified as possible hot spots by MX can be followed up with Mf surveys
and targeted for intervention with MDA or other options. However, use of MX as a primary
surveillance tool requires adequate laboratory facilities, access to supplies, and specially trained
personnel required for this method. As a practical matter, the laboratory analysis of mosquitoes
is less challenging than the mosquito collection activities, which take a long time and are labor
intensive. However, the fact that similar results were obtained by MX in both EUs when the
same number of mosquitoes was collected from fewer collection sites is very important,
because this would greatly reduce costs and increase feasibility for programs. While it is possible that even fewer mosquito trap sites would have yielded similar results, placement of 75 or
150 traps in 30 randomly selected PMHs for collection of 300 pools of 25 mosquitoes/pool per
EU should be feasible for programs interested in using MX as a surveillance method. This
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result was somewhat surprising, and it is possible that mosquito infection rates in these study
areas were unusually homogenous. Additional data will be needed from different areas to
establish whether results from this study are generally applicable to areas with Culex transmission of W. bancrofti. We prefer not to speculate regarding implications of this study for postMDA assessments of areas with filariasis transmission by Anopheles, Mansonia, or Aedes
mosquitoes.
Despite these encouraging results, we recognize that the approach we have used for MX is
not feasible for all national LF elimination programs. One alternative to consider would be to
send mosquitoes to reference centers for qPCR analysis. Another alternative would be to use
traditional dissection and staining methods to detect filarial infection and infectivity in mosquitoes [24–26] even though it is clear that dissection with microscopy is less sensitive than
qPCR. While we do not have firm break points for W. bancrofti transmission by Culex, reviews
have suggested provisional targets of 0.085% for infectivity and 0.65% for mosquito infection
by any parasite stage based on dissection with microscopy [23,27].
An additional point to consider is whether results from this study would also apply in areas
where filarial parasites are transmitted by Anopheles or Aedes mosquitoes. Gravid traps work
well for trapping large quantities of Culex mosquitoes that have fed on human blood, and large
numbers of mosquitoes are needed for accurate estimation of parasite DNA rates in mosquitoes [4,27,28]. Human landing catches and indoor sample collections are less effective than
gravid traps for collecting mosquitoes for MX. It may be possible to adapt sampling methods
used in this study for use with newer mosquito traps that can be used to collect Anopheles or
Aedes vectors [29–33].
MX results obtained in this study were consistent with results obtained by extensive night
blood Mf surveys that tested some 38,000 people, which comprised about 3.5% of the population of Galle district. Like MX, Mf testing on this scale is also expensive and labor intensive. In
addition, mosquito collection using outdoor traps is less intrusive than collection of finger
prick blood samples at night from human subjects. Mf testing showed that 12 of 340 PHM
areas tested had Mf rates 1%. Since PHM areas are equivalent to sentinel or spot check sites
in most countries, EUs with many PHM areas with Mf rates >1% should not have qualified for
TAS. The fact that the coastal Galle EU easily passed TAS illustrates the insensitivity of TAS as
a post-MDA surveillance tool in Sri Lanka.
Although the WHO has suggested the use of MX to supplement TAS [26,34], it has not provided practical guidelines for systematic sampling of mosquitoes. Results of this study should
be helpful for those who are interested in using MX as a surveillance tool at the EU level. One
limitation of the mosquito sampling protocol employed in this study is that mosquitoes were
only collected from about 20% of the clusters (60 of 340 PHMs) in the coastal and inland EUs.
However, some systematic sampling is necessary, because it is not possible to collect random
samples of mosquitoes from all areas in an EU. Fortunately, results in Table 3 show that parasite DNA rates were remarkably similar when parasite DNA rates were calculated for 30 different samples of 30 PHMs drawn from the 60 PHMs sampled in this study. This result provides
support for the validity of the sampling scheme used in this study. Results in Table 3 also
emphasize the importance of using EUs with moderate population sizes that do not mix areas
with vastly different risks for persistent W. bancrofti. Districts are often used as EUs. When
data from the coastal and inland EU were combined, the strong signal of persistent W. bancrofti infection in the coastal area was diluted by negative results from the inland area in a way
that could obscure the need for further intervention in the coastal area.
The AFC considered results from this study and other post-MDA surveillance data from
Galle district and decided to resume MDA in the coastal areas of the district and simply
observe the lower risk inland areas. A repeat MX survey could be used to assess the impact of
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two additional rounds of MDA that were distributed in September of 2014 and 2015. Time will
tell whether MDA alone will solve the problem of persistent W. bancrofti in coastal Galle or
whether anti-mosquito measures or other interventions will be needed in this area.

Conclusions
The Sri Lanka Anti Filariasis Campaign has succeeded in most formerly endemic areas, and
the program has fulfilled many of the criteria required for validation according to WHO guidelines. A prior study compared several different types of tests for detecting persistent W. bancrofti at the level of Public Health Inspector areas with populations of ~25,000. This study has
used MX and Mf testing to document persistence of W. bancrofti in EUs with populations of
500,000 or more. It is well known that the last mile is often the most difficult for elimination
programs. The last 5% is as important as the first 95% when programs are in eradication mode
[35]. We have shown that MX can be used as a sensitive method for detecting and mapping
areas with persistent W. bancrofti. This type of information could be very helpful for planning
interventions to carry programs across the last mile to the finish line.

Supporting Information
S1 Fig. The map shows molecular xenomonitoring results obtained with mosquito pools
collected from gravid traps placed in 3 PHM areas within the Balapitiya MOOH. Waypoints
in red indicate trap locations with 1 or more pools positive for filarial DNA, and locations with
no positive pools are shown in green. Fifty-eight % of trap locations in Balapitiya yielded one
or more mosquito pools that contained filarial DNA.
(TIFF)
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